What is the further workup for hypercalcemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Hypercalcemia (Calcium 11 mg/dL)

Immediately measure intact parathyroid hormone (iPTH) alongside a repeat calcium level to distinguish PTH-dependent from PTH-independent causes—this single test is the most critical step in determining the etiology and subsequent management. 1

Initial Laboratory Assessment

The diagnostic approach hinges on the PTH level:

  • Measure serum intact PTH as the cornerstone test—elevated or inappropriately normal PTH (typically >20 pg/mL) indicates primary hyperparathyroidism, while suppressed PTH points to alternative etiologies 1, 2
  • Obtain corrected calcium if albumin is abnormal to rule out pseudo-hypercalcemia 1
  • Check serum phosphorus—hypophosphatemia suggests hyperparathyroidism, while elevated phosphorus may indicate malignancy or vitamin D toxicity 3
  • Measure serum chloride—hyperchloremic metabolic acidosis is characteristic of hyperparathyroidism 4, 3

PTH-Dependent Hypercalcemia (Elevated or Normal PTH)

When PTH is elevated or inappropriately normal with hypercalcemia, this confirms primary hyperparathyroidism 5, 1:

  • Measure 25-hydroxyvitamin D levels to exclude vitamin D deficiency as a secondary cause of elevated PTH 5, 1
  • Obtain calcitriol (1,25-dihydroxyvitamin D) levels, which are typically elevated in primary hyperparathyroidism 1
  • Refer to endocrinology and experienced parathyroid surgeon for surgical evaluation 5
  • Consider preoperative localization imaging with ultrasound and/or 99mTc-sestamibi scintigraphy with SPECT/CT if surgery is planned 5

Important Caveats for PTH Interpretation

  • PTH assays vary by antibody used and sampling conditions—PTH is more stable in EDTA plasma at 4°C than in serum at room temperature 1
  • Biological factors including race, age, BMI, and vitamin D status influence PTH concentration 1
  • Central blood samples have higher PTH than peripheral samples 1

PTH-Independent Hypercalcemia (Suppressed PTH)

When PTH is suppressed (<20 pg/mL), pursue malignancy and other causes 1, 2:

  • Measure PTH-related peptide (PTHrP)—elevated in humoral hypercalcemia of malignancy, which accounts for 10-25% of lung cancer patients 1
  • Check 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D to identify vitamin D-mediated hypercalcemia from granulomatous disease (sarcoidosis), lymphomas, or vitamin D intoxication 1, 4
  • Evaluate for malignancy if not already diagnosed—malignancy and primary hyperparathyroidism account for >90% of hypercalcemia cases 2, 4
  • Review medication list for thiazide diuretics, calcium supplements, vitamin D, vitamin A, lithium, SGLT2 inhibitors, immune checkpoint inhibitors, or recent denosumab discontinuation 2

Clinical Context Assessment

The clinical presentation helps distinguish etiologies:

  • Primary hyperparathyroidism typically presents with mild hypercalcemia (<12 mg/dL), chronic duration (>6 months), subtle symptoms, history of kidney stones, and no anemia 4, 3
  • Malignancy-associated hypercalcemia presents with rapid onset, higher calcium levels (often >12 mg/dL), severe symptoms, marked anemia, and median survival of approximately 1 month 1, 4
  • Family history of hyperparathyroidism or multiple endocrine neoplasia syndromes favors primary hyperparathyroidism 3

Severity Stratification

At calcium 11 mg/dL, this represents mild hypercalcemia:

  • Mild hypercalcemia (<12 mg/dL or ionized calcium 5.6-8.0 mg/dL) is usually asymptomatic but may cause fatigue and constipation in ~20% of patients 2
  • Assess for symptoms: polyuria, polydipsia, nausea, vomiting, abdominal pain, myalgia, confusion 1
  • Severe hypercalcemia (≥14 mg/dL) requires urgent intervention with hydration and IV bisphosphonates 1, 2

Common Pitfalls

  • Do not rely solely on total calcium without considering albumin levels—always calculate corrected calcium 1
  • Do not assume normal PTH excludes hyperparathyroidism—inappropriately "normal" PTH in the setting of hypercalcemia is diagnostic of primary hyperparathyroidism 1, 2
  • Do not order parathyroid imaging before confirming biochemical diagnosis—imaging is for surgical planning, not diagnosis 5
  • Multivariate analysis using calcium, phosphorus, chloride, and hematocrit achieves 95-98% diagnostic accuracy for hyperparathyroidism 3

References

Guideline

Hypercalcemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hypercalcemia: A Review.

JAMA, 2022

Research

Differential diagnosis of hypercalcemia.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1991

Research

Hypercalcemia: an evidence-based approach to clinical cases.

Iranian journal of kidney diseases, 2009

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.